drugset / Trial / NCT00176891
Stem Cell Transplant w/Laronidase for Hurler
NaSingle-groupOpen-labelTreatment
Summary
The investigators hypothesize that weekly infusions of Laronidase ERT for 10-12 weeks prior to transplant and 8 weeks following transplant will result in a reduction of glycosaminoglycans (GAG) burden that is associated with decreased complications following transplant.
Timeline
- Start
- 2004-03
- Primary completion
- 2012-11
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | laronidase | Protein / enzyme biologic | — | Intravenous |